Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastasesTimothy J. Kaufmann, Benjamin M. Ellingson, Evanthia Galanis et al.|Neuro-Oncology|2020Cited by 258
Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastomaBianca M. Marin, Jann N. Sarkaria, Kendra A. Porath et al.|Neuro-Oncology|2021Cited by 81
Efficacy of the MDM2 Inhibitor SAR405838 in Glioblastoma Is Limited by Poor Distribution Across the Blood–Brain BarrierMinjee Kim, Jann N. Sarkaria, J. Daniel et al.|Molecular Cancer Therapeutics|2018Cited by 40
A hitchhiker’s guide to cerebrospinal fluid biomarkers for neuro-oncologyCécile Riviere-Cazaux, Terry C. Burns, Michael B. Keough et al.|Neuro-Oncology|2024Cited by 15
Data from Efficacy of the MDM2 Inhibitor SAR405838 in Glioblastoma Is Limited by Poor Distribution Across the Blood–Brain BarrierMinjee Kim, Jann N. Sarkaria, J. Daniel et al.|Unknown|2023Cited by 0